Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients

Bone Marrow Transplantation

Volumn 50, Issue , 2015, Pages S6-S10

  Lang, P ^a   Feuchtinger, T ^a   Teltschik, H M ^a   Schwinger, W ^b   Schlegel, P ^a   Pfeiffer, M ^a   Schumm, M ^a   Lang, A M ^a   Lang, B ^a   Schwarze, C P ^a   Ebinger, M ^a   Urban, C ^b   Handgretinger, R ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; CLOFARABINE; FLUDARABINE; HYDROCORTISONE; MELPHALAN; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; OKT 3; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; THIOTEPA; THYMOCYTE ANTIBODY; LYMPHOCYTE ANTIGEN RECEPTOR;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGRAFT; ALLOTRANSPLANTATION; ARTICLE; CD3+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DONOR; ENGRAFTMENT; GAMMA DELTA T LYMPHOCYTE; GRAFT REJECTION; HAPLOIDENTICAL STEM CELL TRANSPLANTATION; HUMAN; IMMUNE RECOVERY; IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; JUVENILE MYELOMONOCYTIC LEUKEMIA; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; REFRACTORY ANEMIA WITH EXCESS BLASTS IN TRANSFORMATION; REPEATED DRUG DOSE; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; B LYMPHOCYTE; CONVALESCENCE; DEVICES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; LEUKEMIA, MYELOID, ACUTE; LYMPHOCYTE DEPLETION; MALE; MYELODYSPLASTIC SYNDROMES; PRESCHOOL CHILD; PROCEDURES; T LYMPHOCYTE;

ADOLESCENT; ALLOGRAFTS; ANTIGENS, CD19; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; LYMPHOCYTE DEPLETION; MALE; MYELODYSPLASTIC SYNDROMES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; T-LYMPHOCYTES; TISSUE DONORS; TRANSPLANTATION CONDITIONING;

EID: 84930463453     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2015.87     Document Type: Article

References (12)

1. Reisner Y, Hagin D, Martelli MF. Haploidentical hematopoietic transplantation: current status and future perspectives. Blood 2011; 118: 6006-6017.
2. Aversa F, Terenzi A, Tabilio A, Falzetti F, Carotti A, Ballanti S et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 2005; 23: 3447-3454.
3. Handgretinger R, Klingebiel T, Lang P, Schumm M, Neu S, Geiselhart A et al. Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant 2001; 27: 777-783.
4. Ortin M, Raj R, Kinning E, Williams M, Darbyshire PJ. Partially matched related donor peripheral blood progenitor cell transplantation in paediatric patients adding fludarabine and anti-lymphocyte gamma-globulin. Bone Marrow Transplant 2002; 30: 359-366.
5. Klingebiel T, Cornish J, Labopin M, Locatelli F, Darbyshire P, Handgretinger R et al. Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group. Blood 2010; 115: 3437-3446.
6. Lang P, Greil J, Bader P, Handgretinger R, Klingebiel T, Schumm M et al. Long-term outcome after haploidentical stem cell transplantation in children. Blood Cells Mol Dis 2004; 33: 281-287.
7. Marks DI, Khattry N, Cummins M, Goulden N, Green A, Harvey J et al. Haploidentical stem cell transplantation for children with acute leukaemia. Br J Haematol 2006; 134: 196-201.
8. Peters C, Matthes-Martin S, Fritsch G, Holter W, Lion T, Witt V et al. Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment. Leukemia 1999; 13: 2070-2078.
9. Schumm M, Lang P, Bethge W, Faul C, Feuchtinger T, Pfeiffer M et al. Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device. Cytotherapy 2013; 15: 1253-1258.
10. Schumm M, Handgretinger R, Pfeiffer M, Feuchtinger T, Kuci S, Faul C et al. Determination of residual T-and B-cell content after immunomagnetic depletion: proposal for flow cytometric analysis and results from 103 separations. Cytotherapy 2006; 8: 465-472.
11. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
12. Otto M, Barfield RC, Iyengar R, Gatewood J, Muller I, Holladay MS et al. Human gammadelta T cells from G-CSF-mobilized donors retain strong tumoricidal activity and produce immunomodulatory cytokines after clinical-scale isolation. J Immunother 2005; 28: 73-78.